Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Pediatric liver disease".)
International
●World Health Organization (WHO): Recommendations on maternal and newborn care for a positive postnatal experience (2022)
●Academy of Breastfeeding Medicine (ABM): Clinical protocol #22 − Guidelines for management of jaundice in the breastfeeding infant 35 weeks or more of gestation, revised (2017)
●WHO: Recommendations on newborn health (2017)
Canada
●Canadian Paediatric Society (CPS): Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (2007, reaffirmed 2018)
●Choosing Wisely Canada: Don't delay testing for total and conjugated (direct) bilirubin in any newborn with persistent jaundice beyond 2 weeks of age (2017)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Guideline for the evaluation of cholestatic jaundice in infants (2017)
United States
●American Academy of Pediatrics (AAP): Clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, revision (2022)
●AAP: Technical report for the diagnosis and management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation (2022)
●AAP: Technical report on phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation (2011, reaffirmed 2022)
●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on delayed umbilical cord clamping after birth (2017)
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Guideline for the evaluation of cholestatic jaundice in infants (2017)
●AAP: Technical report on newborn screening for biliary atresia (2015)
●American Academy of Family Physicians (AAFP): Evaluation and treatment of neonatal hyperbilirubinemia (2014)
●National Association on Neonatal Nurses (NANN): Position statement for the prevention of acute bilirubin encephalopathy and kernicterus in newborns (2010)
Europe
●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Guideline for the evaluation of cholestatic jaundice in infants (2017)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Clinical guideline on jaundice in newborn babies under 28 days (2010, updated 2016)
●NICE: Quality standard on jaundice in newborn babies under 28 days (2014)
Australia-New Zealand
●Ministry of Health, New South Wales (NSW): Guideline on neonatal jaundice identification and management in neonates ≥32 weeks gestation (2016)
